Important Announcement

X

ChemIDplus is moving to PubChem in December 2022.
Please see the NLM Technical Bulletin article for more information.

Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Anifrolumab [USAN:INN]
RN: 1326232-46-5
UNII: 38RL9AE51Q

Note

  • In phase I clinical trials for treatment of systemic sclerosis; directed against type I IFN-alpha receptor.

Molecular Formula

  • C6444-H9964-N1712-O2018-S44
 

Classification Code

  • Treatment of Systemic Lupus Erythematosus (SLE)
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Anifrolumab [USAN:INN]

Synonyms

  • Anifrolumab
  • MEDI 546
  • MEDI-546
  • UNII-38RL9AE51Q

Registry Numbers

CAS Registry Number

  • 1326232-46-5

FDA UNII

  • 38RL9AE51Q

System Generated Number

  • 1326232465